Glytone Rejuvenating Cream 20 50 ml opaque tube with 15% PFAV glycolic acid
Supporting role for Aging
What Makes This Different

Most leave-on glycolic products top out at 8-10% PFAV (The Ordinary's 7% Toning Solution, Paula's Choice 8% Resist Weekly), or split high doses into peel-format products that require timer-based wash-off. Glytone's 15% PFAV in a leave-on cream is one of the highest non-prescription daily glycolic concentrations available, engineered with a silicone-and-emollient vehicle that makes the high dose tolerable for normal-to-dry skin types.

Glytone

Glytone Rejuvenating Cream 20 Review

Clinical High-Dose Glycolic Cream
moisturizer cream clinical Paraben Free Cruelty Free

A high-dose leave-on glycolic cream at 15% Pure Free Acid Value — one of the highest non-prescription daily glycolic concentrations on the market — engineered with a silicone-emollient vehicle that makes the aggressive dose tolerable for tolerance-built normal-to-dry users. Brings dermatology-office peel-tier exfoliation into a daily-use moisturizer format at a fraction of the per-session in-office cost.

$45.00
50 ml
4.4 ★★★★★
380 reviews
Made in United States Launched 2005 All-year use PAO: 12 months
Buy at Amazon ♥
Run it through our tools Clashes with my routine? Pregnancy-safe? Find a cheaper dupe Patch-test it first
Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Supporting rolefor AgingGlycolic Acid has early evidence for aging, and hydration and barrier support is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has early or mechanistic evidence for this concern, not trial-backed standing.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: Trial evidence for the active on this concern would move this from a bet to a recommendation.

Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R8a decided 1,489 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active
Glycolic Acid
Standing
plausible — trials support it
Form
adequate (declared 15%) — studied range 5–10%, from the OTC monograph or label; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All aging products →
Good choicefor Rough TextureGlycolic Acid is a reference standard by mechanism for rough texture; this cream carries it at 15%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has trial-supported standing for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Glycolic Acid
Standing
supported — its mechanism is established
Form
adequate (declared 15%) — studied range 4–10%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

  • International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
  • Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
All rough texture products →
Good choicefor DullnessGlycolic Acid is a reference standard by mechanism for dullness; this cream carries it at 15%.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has trial-supported standing for this concern.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Glycolic Acid
Standing
supported — its mechanism is established
Form
adequate (declared 15%) — studied range 4–10%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

  • Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
All dullness products →
Promisingfor HyperpigmentationGlycolic Acid has trial-level evidence for hyperpigmentation but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Glycolic Acid
Standing
plausible — trials support it
Form
adequate (declared 15%) — studied range 5–10%, from the OTC monograph or label; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All hyperpigmentation products →
Promisingfor Sun DamageGlycolic Acid has trial-level evidence for sun damage but no guideline or regulatory standing yet — promising, short of a recommendation; the other actives here are not yet assessed for it.Moderate evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has trial-level evidence for this concern but no guideline or regulatory standing yet.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

Cautions: a photosensitising active — use sun protection.

What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.

Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R9p — 0.5.0: 'Unproven' beside three filled dots read as one question answered twice with opposite words (7,018 rows). The chip measures standing, the dots measure trial volume; where the row carries at least one RCT or a tier-2 source (moderate dots) and the active is present at a working level, the honest word is Promising. Unproven is reserved for plausible-standing rows with limited or weak evidence, or an under-dosed form. Same rank as Unproven — a bet either way; the dots order them. · the full register
Carrying active
Glycolic Acid
Standing
plausible — trials support it
Form
adequate (declared 15%) — studied range 5–25%, from the OTC monograph or label; needs leave-on contact; judge it after ~8 weeks
Tolerability
standard — photosensitization
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All sun damage products →
Supporting rolefor Keratosis PilarisGlycolic Acid has early evidence for keratosis pilaris, and emollient hydration is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Limited evidenceStandard tolerabilityNo reviews collected yet

The case for it

  1. Glycolic Acid has early or mechanistic evidence for this concern, not trial-backed standing.
  2. It is present at an effective concentration, declared or high in the ingredient list.
  3. The formula carries no trigger this concern is sensitive to, with the cautions noted.

What would change this: Trial evidence for the active on this concern would move this from a bet to a recommendation.

Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R8a decided 1,489 of them. Unchanged since September 5, 2026, engine 5.1.1.

Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active
Glycolic Acid
Standing
plausible — trials support it
Form
adequate (declared 15%)
Tolerability
standard
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

All keratosis pilaris products →

Does the jobDoes what a moisturizer is for: draws in water, softens and smooths.

Where our review and the verdict differ. The review below was written on the formulation and the published trials; the verdicts above apply the stricter standing test in our methodology — an active earns a recommendation only with guideline or regulatory standing for the concern. Where the two disagree, the verdict is DermApproved’s position.

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • ✓ 15% PFAV glycolic is one of the highest non-prescription daily glycolic concentrations
  • ✓ Silicone-emollient vehicle engineering makes the high dose tolerable
  • ✓ Functions as an at-home alternative to dermatology-office glycolic peels
  • ✓ PFAV labeling more honest than typical percentage-based marketing
  • ✓ Cream format combines exfoliation and moisturization in one step
  • ✓ Pierre Fabre clinical heritage backs the formulation
  • ✓ Strong value vs in-office glycolic peel sessions

Cons

  • ✗ Aggressive dose narrows the appropriate user audience meaningfully
  • ✗ Requires strict PM-only, no-other-actives application discipline
  • ✗ Mandatory daily SPF 50+ — non-negotiable safety requirement
  • ✗ Sweet almond oil rules it out for tree-nut-allergy users
  • ✗ Silicone-heavy texture not loved by silicone-averse users
  • ✗ First-week tingling can deter users from building tolerance
Review

Full Review

Most leave-on glycolic acid products in the over-the-counter category cap out around 8-10% PFAV. The Ordinary's Glycolic Acid 7% Toning Solution sits below that range; Paula's Choice 10% AHA Skin-Smoothing Treatment marks the boundary; SkinCeuticals C E Ferulic's adjacent glycolic products land in the same neighborhood. Products that go higher — 15%, 20%, 30% glycolic — are almost universally wash-off peel formats that require timer-based application and immediate neutralization. Glytone's Rejuvenating Cream 20 is the unusual exception: a 15% PFAV leave-on cream that combines dermatology-office peel-tier exfoliation with daily-use moisturizer convenience, sold without prescription through dermatology offices and clinical e-tailers.

The naming is worth a brief explanation. The '20' refers to total glycolic acid (free acid plus salt form combined); the bioactive Pure Free Acid Value, which is what matters clinically, is 15%. Glytone's PFAV labeling system is more honest than the percentage-based marketing competitors use, but the dual labeling on this product's name can confuse first-time buyers. The 15% PFAV at pH 3.7 means the glycolic is operating at near-maximum bioactivity — most of the acid molecules are in their active form rather than the inert salt form. For comparison, a competitor's '15% glycolic acid' product at pH 4.5 might have a PFAV closer to 8-9%, which is why Glytone's labeling matters.

The vehicle engineering is what makes the 15% PFAV tolerable as a leave-on product. Dimethicone and trisiloxane silicones at the third and sixth INCI positions provide both the smooth slip that allows even application and the occlusive film that slows transepidermal water loss after the acid does its work. Sweet almond oil contributes oleic-and-linoleic-acid emollient support. Glycerin and propylene glycol add humectant pull. The whole vehicle is deliberately designed to buffer the aggressive acid load — without this engineering, 15% PFAV glycolic on dry skin would be intolerably irritating for most users. With this engineering, it's manageable for tolerance-built users on normal-to-dry skin three to four nights per week.

In use, the experience over the first eight weeks is genuinely the at-home-glycolic-peel experience the cream is positioned as. Week one is mostly tingling and adjustment — applications produce a 5-15 minute warming sensation that fades, and mild surface dryness emerges by night three or four. Light flaking is common in week two as the cumulative stratum corneum turnover accumulates. By week three, the visible smoothing and brightening payoff begins — surface texture looks meaningfully refined, dull patches brighten, the small dehydration lines around the eyes and mouth that exaggerate aging become less prominent. Between weeks four and eight, the cumulative effect on fine lines, hyperpigmentation, sun-induced dark spots, and overall photoaging metrics reaches the visible plateau that consistent use can produce. By the eight-to-twelve-week mark, users are in the maintenance phase where the cream's job is preserving the progress rather than producing new visible improvements.

Where the product is the wrong choice is the long list of contraindications. Sensitive, rosacea-prone, eczema-prone, or actively reactive skin should not approach a 15% PFAV daily glycolic — the irritation potential compounds with any existing reactivity. Anyone using prescription retinoids or other strong actives in the same routine should not stack this cream same-night; the cumulative load risks barrier damage even for tolerant users. Strict daily SPF 50+ is mandatory — glycolic acid increases UV sensitivity for up to a week after the last application, and skipping SPF after using this cream literally accelerates the photoaging you're trying to treat. Tree-nut-allergy users should check the sweet almond oil content. Fungal-acne avoiders should look elsewhere given the comedogenic potential.

The value calculation against alternatives is genuinely interesting. Dermatology-office glycolic peels typically run $50-$150 per session and require 4-6 sessions for cumulative results — a $200-$900 investment for results that this cream can substantially replicate over 8-12 weeks at $45 for a 3-4 month supply. The Ordinary 7% Glycolic at $9 provides lower-dose maintenance exfoliation; Paula's Choice 10% AHA at $34 occupies the middle tier. The Glytone is in a small category of non-prescription products that provide genuinely peel-tier daily glycolic exposure. For tolerance-built users running comprehensive anti-aging routines, the price is fair for what the product delivers. For users uncertain whether they can tolerate the dose, starting with a lower-strength leave-on glycolic and graduating to this cream after building tolerance is the safer approach.

Who actually wins from this cream? Tolerance-built photoaging users in the 35-65 range with normal-to-dry skin who have outgrown 7-10% glycolic products and want the next tier without committing to in-office peels. Users with moderate hyperpigmentation, sun damage, or photoaging concerns who appreciate the at-home alternative to dermatology peel sessions. Patients buying within their dermatologist's recommended product line. Long-term routine builders who want their evening moisturizer doing meaningful exfoliation work without a separate treatment serum step.

Who should skip? First-time glycolic users — start with The Ordinary 7% or Paula's Choice 10% to build tolerance before approaching this dose. Sensitive, rosacea-prone, or eczema-prone skin — the irritation risk compounds with any reactivity. Users running active retinoid routines who can't accommodate the no-other-actives discipline this cream requires. Pregnant users at the more cautious end of the pregnancy-safety spectrum, since alternatives exist with lower acid loads.

The honest assessment is that this is one of the most aggressive non-prescription daily glycolic products available, engineered with enough vehicle sophistication to be genuinely usable rather than just a label claim. The PFAV labeling is more honest than competitors. The cream format is the right vehicle for high-dose acid delivery. The dermatology-office distribution context is legitimate. Whether it's the right product for you comes entirely down to your tolerance level, application discipline, and willingness to maintain strict SPF habits. For the user it's designed for, this is one of the most credible at-home alternatives to in-office glycolic peels at a fraction of the per-session cost. For everyone else, it's an over-aggressive choice that will produce more irritation than benefit.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
Glycolic Acid (15% PFAV / 20% total) (15%) The dominant active in this leave-on cream — Glytone uses the '20' in the product name to refer to total glycolic acid (free acid plus salt form), but the bioactive Pure Free Acid Value is 15%. That 15% PFAV is in the upper tier of leave-on glycolic concentrations available outside of in-clinic peel formulations, and at pH 3.7 it's working at maximum bioactivity for stratum corneum turnover, collagen stimulation, and pigmentation pathway intervention. Established mechanism for Rough Texture · established mechanism
Dimethicone + Trisiloxane Silicone fluids at the third and sixth INCI positions form the occlusive backbone of the cream, providing a smooth slip that lets the high-dose glycolic apply evenly without piling. The silicone film also serves a buffering function — it slows transepidermal water loss after a strong acid application, which is part of why this 15% PFAV cream is more tolerable than a comparable acid serum would be at the same dose. The silicone vehicle is deliberately engineered for high-dose acid delivery. Not yet assessed
Sweet Almond Oil Provides emollient counterweight to the aggressive acid load, contributing oleic and linoleic acids that soften the post-application tightness this high-dose glycolic would otherwise produce. The choice of almond oil specifically rather than mineral oil or pure petrolatum signals a barrier-supportive rather than purely occlusive strategy — appropriate for the normal-to-dry skin demographic this cream targets. Not yet assessed
Glycerin The humectant base that pulls water into the stratum corneum to offset the dehydration that high-dose glycolic can cause. In this formula glycerin sits mid-INCI, working with the silicones and sweet almond oil as the supportive moisture layer that distinguishes this leave-on glycolic from the typical 'acid serum' that requires its own moisturizer layered on top. Plausible mechanism for Dullness
Full INCI List · pH 3.7

Aqua, Glycolic Acid, Dimethicone, Sodium Hydroxide, Cetearyl Alcohol, Trisiloxane, Isostearyl Palmitate, Glyceryl Stearate SE, Magnesium Aluminum Silicate, Bis-Hydroxyethoxypropyl Dimethicone, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Glycerin, Hydrogenated Vegetable Oil, Silica, Cetearyl Glucoside, Polysorbate 20, Ceteth-10, Polyacrylamide, Laureth-4, Propylene Glycol

Safety & Formulation Facts
✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✗ Oil Free✗ Silicone Free✓ Paraben Free✓ Sulfate Free✓ Cruelty Free✗ Vegan✗ Fungal Acne Safe
Comedogenic Ingredients
Sweet Almond OilIsostearyl Palmitate
Potential Irritants
Glycolic AcidSweet Almond OilPropylene Glycol
Common Allergens
Sweet Almond Oil
Compatibility

Skin Match

Best For
Works For
Not Ideal For
Routine Step

moisturizer

Time of Day

PM

Layering Tips

Apply at night after cleansing on dry skin — water on the skin can dilute the formula or cause stinging. Use as the final treatment-moisturizer step. Do not layer additional AHAs, BHAs, or retinoids on the same night. Always wear SPF 50+ during the day; glycolic increases UV sensitivity for up to a week after the last application.

Results Timeline

Immediate: a 5-15 minute warming tingle that fades into a slightly tighter post-application finish. 1-2 weeks: visible smoothing of surface texture, brighter overall tone. 4-8 weeks: meaningful improvement in fine lines, hyperpigmentation, and rough texture. 12+ weeks: maximum payoff for users tolerating consistent use — the cream functions as a non-prescription alternative to dermatology-office glycolic peels at a fraction of the per-session cost.

Pairs Well With
ceramideshyaluronic-acidniacinamideazelaic-acid
Planning a combo? Check it against what you already use
Conflicts With
retinolhigh-strength-aha-bhabenzoyl-peroxidevitamin-c-l-ascorbic
See where it fits — layering order & night-splitting
Sample AM Routine
  1. Gentle non-acid cleanser
  2. Antioxidant serum
  3. Moisturizer
  4. SPF 50+
Sample PM Routine
  1. Cleanser
  2. Hydrating toner (optional)
  3. Glytone Rejuvenating Cream 20
  4. Ceramide cream on top (optional for very dry skin)
Evidence

Science & Expert Perspective

The Science

High-dose leave-on glycolic acid has been studied extensively for photoaging and pigmentation since the 1990s. Newman et al. (1996) in Dermatologic Surgery demonstrated that 12-15% leave-on glycolic acid produced statistically significant improvement in fine lines, mottled hyperpigmentation, and surface roughness over 12 weeks of consistent use. The dose-response curve flattens above approximately 15% PFAV — going higher mostly increases irritation rather than measurable photoaging improvement, which is why the 15% PFAV in this cream sits at the practical efficacy ceiling for daily leave-on use.

The mechanism is well-characterized. Glycolic acid dissolves the desmosomal connections holding corneocytes together in the stratum corneum, accelerating the natural shedding cycle. At the high concentration in this cream, the effect extends beyond surface exfoliation into deeper stratum granulosum modulation, dermal fibroblast collagen stimulation (Bernstein et al., 2001), and tyrosinase pathway inhibition for pigmentation. The pH at 3.7 is critical — at this pH, predominantly the bioactive free acid form is present, which is what the PFAV labeling captures.

The vehicle engineering deserves note. The silicone-and-emollient base in this cream is supported by extensive cosmetic chemistry research on glycolic acid delivery systems — high-dose acid in a barrier-supportive vehicle produces more tolerable exfoliation than the same dose in a water-based serum vehicle. The combination of dimethicone, trisiloxane, sweet almond oil, and glycerin in this formula is a deliberate engineering choice supported by tolerability studies, even though the specific Glytone formulation hasn't been independently trialed in published research. The supporting hydrogenated vegetable oil and isostearyl palmitate contribute to the barrier-mimicking properties that distinguish this cream from a basic acid serum.

References
  1. Glycolic acid-induced photodamage repair — Dermatologic Surgery (1996)
  2. Effects of topical glycolic acid on photoaged skin — Journal of the American Academy of Dermatology (2001)

Dermatologist Perspective

Dermatologists frequently recommend high-strength at-home glycolic creams like this Glytone product for patients with moderate photoaging, mild-to-moderate hyperpigmentation, or coarse-textured skin who want at-home maintenance between in-office peel sessions. Working dermatologists commonly point out that 15% PFAV in a leave-on cream represents the upper end of what's appropriate for non-supervised use, and consistently recommend strict tolerance-building protocols (start 2-3 nights per week, advance gradually) and rigid no-other-actives discipline. The pregnancy-safe profile makes it an appropriate retinoid substitute for pregnant patients with photoaging concerns, though many dermatologists prefer lower-strength alternatives during pregnancy out of caution. SPF 50+ is universally emphasized as non-negotiable for glycolic users at this dose level.

Guidance

Usage & Recommendations

How to Use

Apply at night after cleansing on dry, fully-toweled skin — water on the skin can dilute the formula or amplify stinging. Use a pea-sized amount for the full face. Avoid the immediate eye area and any actively broken or irritated skin. Start with 2-3 nights per week for the first 2-3 weeks while building tolerance. Advance to 3-4 nights per week after week 3. Most users stabilize at 3-4 nights per week as the sustainable long-term cadence. Never combine same-night with retinol, other AHAs, BHAs, vitamin C serums, or benzoyl peroxide. Mandatory SPF 50+ during the day, including on days you don't use the cream — glycolic increases UV sensitivity for up to a week after the last application.

Value Assessment

At $45 for 50ml, this cream is positioned in the upper-mid clinical tier. The 3-4 month supply at proper PM-only application (3-4 nights per week) puts the cost-per-month at $11-$15. Comparable benchmarks: Paula's Choice 10% AHA Skin-Smoothing Treatment at $34 (lower dose); The Ordinary 7% Toning Solution at $9 (entry-tier); MD Solar Sciences Daily Anti-Aging Moisturizer at $52 (peer-tier); in-office glycolic peels at $50-$150 per session typically requiring 4-6 sessions for cumulative results. The Glytone's value calculation depends on whether the 15% PFAV vs lower-dose alternatives justifies the moderate price premium, and whether the in-office peel substitution is a relevant comparison for your routine.

Who Should Buy

Tolerance-built users with normal-to-dry skin in the 35-65 age range dealing with photoaging, moderate hyperpigmentation, sun damage, or coarse-textured skin who have outgrown 7-10% glycolic products. A particularly strong choice for patients wanting an at-home alternative to dermatology-office glycolic peels, and for routine builders who want their evening moisturizer doing exfoliation work without a separate treatment serum step. Also appropriate as a retinoid substitute during pregnancy for the photoaging demographic.

Who Should Skip

Skip if you're new to leave-on glycolic — start with The Ordinary 7% or Paula's Choice 10% to build tolerance before approaching this dose. Sensitive, rosacea-prone, eczema-prone, or actively reactive skin should not approach this product. Users running active prescription retinoid routines who can't accommodate the no-other-actives discipline should look for lower-strength alternatives that don't require such strict pairing rules. Oily skin types may find the silicone-heavy occlusive vehicle too rich.

Ready to try Glytone Rejuvenating Cream 20?

Buy at Amazon ♥

Or visit the Glytone store on Amazon →

Details

Product Details

Texture

Rich, opaque cream with a silky silicone slip

Scent

Essentially scentless

Packaging

Opaque tube — protects the glycolic acid from light degradation

Finish
satinnon-greasylightweight
What to Expect on First Use

First applications produce a noticeable 5-15 minute warming tingle on contact with the high-dose glycolic acid. This is normal and not a sign of damage. Mild surface dryness or light flaking is common in weeks 2-3 as the cumulative exfoliation accumulates. Start with 2-3 nights per week and build tolerance gradually before attempting nightly use. Always patch test on the jawline before full-face application.

How Long It Lasts

3-4 months at proper PM-only application 3-4 nights per week

Period After Opening

12 months

Opened yours? Track the toss-by date
Best Season

All Year

Background

The Story Behind This Product

Glytone introduced the Rejuvenating Cream 20 in 2005 as the highest-strength tier of its leave-on glycolic line, designed as an at-home equivalent to dermatology-office glycolic facials for patients building tolerance from the brand's lower-strength 10% and 15% variants. The cream vehicle was specifically engineered for high-dose acid delivery — most 15% PFAV products are wash-off peel formats because the cream-vehicle engineering required for tolerability is non-trivial.

About Glytone Established Brand (5–20 years)

Glytone was founded in 1996 by Pierre Fabre Dermo-Cosmetique as a US clinical brand built around glycolic acid technology, distributed primarily through dermatology offices. The Rejuvenating Cream 20 represents the high-end of Glytone's daily glycolic moisturizer line and has been a dermatology-office staple for nearly two decades.

Brand founded: 1996 · Product launched: 2005
Myth vs. Reality

Common Myths

Myth

Glycolic acid stronger than 10% is dangerous for home use.

Reality

High-dose glycolic acid in a tolerable vehicle, used with proper application discipline (PM only, no other actives, strict SPF) is widely used by tolerance-built users and supported by published clinical evidence. The 'dangerous' framing usually comes from products formulated without proper vehicle engineering or used incorrectly. This Glytone formula has nearly two decades of dermatology-office distribution without significant safety issues.

Myth

Higher-strength glycolic always produces faster results.

Reality

The dose-response curve for glycolic plateaus above 12-15% PFAV — going higher mostly increases irritation rather than benefit. The 15% in this cream is at the practical efficacy ceiling for daily leave-on use. The reason for going higher than 8-10% products is the cumulative payoff over consistent weekly use, not faster single-application results.

FAQ

Frequently Asked Questions

What does the '20' in the product name mean?

The '20' refers to the total glycolic acid percentage (free acid plus salt form), but the bioactive Pure Free Acid Value (PFAV) is 15%. PFAV is the metric that matters for clinical activity — it tells you how much glycolic is in its active acid form engaging your skin chemistry. The 15% PFAV is in the upper tier of leave-on glycolic concentrations.

Can I use it every night?

Not from day one. Start 2-3 nights per week for the first 2-3 weeks to build tolerance. Most users stabilize at 3-4 nights per week as the sustainable long-term cadence; nightly use is typically too aggressive even for tolerance-built users. Listen to your skin — if dryness, flaking, or stinging persists past 30 minutes, reduce frequency.

Can I use my retinol on the same night?

No — never combine 15% PFAV glycolic with retinol same-night. The cumulative acid-plus-retinoid load is highly irritating and risks barrier compromise even for tolerant users. Alternate evenings (glycolic one night, retinol the next), or designate this product as your AHA cream and use a separate dedicated retinol routine.

Is Rejuvenating Cream 20 pregnancy-safe?

Glycolic acid at OTC concentrations is generally considered safe during pregnancy and breastfeeding, including this 15% PFAV cream. However, the silicone content and the moderate-to-high acid dose mean it's not the gentlest option — many dermatologists prefer pregnant patients use lower-strength alternatives. Consult your OB about your specific case.

How does it compare to Paula's Choice 10% AHA Skin-Smoothing Treatment?

Paula's Choice 10% AHA at $34 is a leave-on serum with 10% glycolic acid in a lighter vehicle. Glytone's Rejuvenating Cream 20 at $45 is a cream with 15% PFAV (~20% total) in a richer silicone-emollient vehicle. The Glytone provides stronger exfoliation in a more occlusive base; the Paula's Choice is gentler and more versatile. For tolerance-built users wanting maximum non-prescription glycolic exposure, Glytone wins. For most users, Paula's Choice is the safer entry point.

Will it really replace dermatology-office glycolic peels?

Partially — consistent at-home use over 8-12 weeks can produce results comparable to a series of light in-office peels at substantially lower cost. But it doesn't replace deeper professional peels (30%+ glycolic, TCA, Jessner's) which work at concentrations and pH that require medical supervision. Think of this as the at-home maintenance tier that complements rather than replaces periodic deeper in-office treatments.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

Visible smoothing and brightening within 2-3 weeks

Cream vehicle is more tolerable than a 15% PFAV serum would be

Lasts users 3-4 months at proper PM-only application

Strong value vs in-office glycolic peel sessions

Genuine clinical-tier exfoliation without prescription

Common Complaints

First-week tingling can feel intense

Requires strict no-other-actives discipline in the same routine

Sweet almond oil rules it out for tree-nut-allergy users

Silicone-heavy texture not loved by silicone-averse users

Strong SPF 50+ requirement during the day

Notable Endorsements
Distributed through dermatology offices and clinical e-tailersFrequently recommended as an at-home alternative to in-office glycolic peels
Related Conditions
agingrough texturedullnesshyperpigmentationsun damagekeratosis pilaris
Related Ingredients
glycolic aciddimethiconesweet almond oilglycerin